Polianta Ltd’s Elevance Health ELV Stock Holding History

Polianta Ltd’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82M	Sell	4,700 -700	-13%	-$260K	0.22%	48
2026 Q1	$1.58M	Buy	5,400 +900	+20%	+$296K	0.21%	30
2025 Q4	$1.58M	Hold	4,500	–	–	0.21%	29
2025 Q3	$1.45M	Buy	+4,500	New	+$1.4M	0.6%	41
2023 Q3	–	Sell	-2,500	Closed	-$1.11M	–	79
2023 Q2	$1.11M	Buy	+2,500	New	+$1.15M	0.51%	29
2020 Q4	–	Sell	-4,600	Closed	-$1.24M	–	72
2020 Q3	$1.24M	Buy	+4,600	New	+$1.24M	0.73%	17
2018 Q2	–	Sell	-4,800	Closed	-$1.05M	–	84
2018 Q1	$1.05M	Sell	4,800 -1,300	-21%	-$305K	0.32%	69
2017 Q4	$1.37M	Hold	6,100	–	–	0.45%	30
2017 Q3	$1.16M	Hold	6,100	–	–	0.37%	59
2017 Q2	$1.15M	Buy	+6,100	New	+$1.1M	0.48%	38

Other funds holding ELV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Polianta Ltd's ELV Position: Q2 2026 in Review

Polianta Ltd reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $260K and leaving 4,700 shares worth $1.82M. The position accounts for 0.22% of the portfolio, ranked #48.

Polianta Ltd first reported a position in ELV in Q2 2017 and has held it in 10 quarters since. 331 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Polianta Ltd held 4,700 shares of Elevance Health worth $1.82M as of Q2 2026.
Polianta Ltd sold 700 Elevance Health shares in Q2 2026, an estimated $260K.
Elevance Health made up 0.22% of Polianta Ltd's portfolio in Q2 2026, its #48 holding.
Polianta Ltd first reported a position in Elevance Health in Q2 2017 and has held it in 10 quarters since.
331 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Polianta Ltd's 13F filing for Q2 2026, filed 8 Jul 2026.